Spots Global Cancer Trial Database for Faslodex Post Marketing Surveillance
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Faslodex Post Marketing Surveillance
Official Title: Faslodex Post Marketing Surveillance
Study ID: NCT00860561
Conditions
Interventions
Study Description
Brief Summary: This PMS aims to assess the efficacy, the safety and tolerability profile of Faslodex in everyday practice. Secondary objective of this PMS is to identify the frequency of serious adverse events or any unknown adverse events of Faslodex.
Detailed Description:
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Research Site, Cheonan, , Korea, Republic of
Research Site, Daegu, , Korea, Republic of
Research Site, Daejeon, , Korea, Republic of
Research Site, Iksan, , Korea, Republic of
Research Site, Jeonju, , Korea, Republic of
Research Site, Seoul, , Korea, Republic of
Research Site, Suwon-si, , Korea, Republic of
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
